Six participants experienced hypoglycemia (glucose <3.9 mmol/L [<70 mg/dL]) during the control arm, five during the reduced basal insulin infusion rate arm and none during the oral glucose and MDG arms. This evidence concerns the gene INS and Hypoglycemia.